<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">Cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) is a major contributor to morbidity and mortality in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but the relationship between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is not well understood </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:mp ids='MP_0002055'>Diabetes</z:mp> Heart Study is a study of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>-enriched families extensively phenotyped for measures of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A total of 977 Caucasian subjects from 358 pedigrees (575 type 2 diabetic relative pairs) with at least two individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and, where possible, unaffected siblings were included in a genome scan </plain></SENT>
<SENT sid="3" pm="."><plain>Qualitative traits evaluated in this analysis are with or without the presence of coronary calcified plaque (<z:chebi fb="97" ids="35889">CCP</z:chebi>) and with or without carotid calcified plaque (CarCP) measured by electrocardiogram-gated helical computed tomography </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, prevalent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> was measured using two definitions: CVD1, based on self-reported history of clinical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (393 subjects), and CVD2, defined as CVD1 and/or <z:chebi fb="97" ids="35889">CCP</z:chebi> &gt;400 (606 subjects) </plain></SENT>
<SENT sid="5" pm="."><plain>These discrete traits (type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, CVD1, CVD2, <z:chebi fb="97" ids="35889">CCP</z:chebi>, and CarCP) frequently coincide in the same individuals with concordance ranging from 42.9 to 99% </plain></SENT>
<SENT sid="6" pm="."><plain>Multipoint nonparametric linkage analysis revealed evidence for coincident mapping of each trait (type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, CVD1, CVD2, <z:chebi fb="97" ids="35889">CCP</z:chebi>, and CarCP) to three different genomic regions: a broad region on chromosome 3 (70-160 cM; logarithm of odds [LOD] scores ranging between 1.15 and 2.71), chromosome 4q31 (peak LOD 146 cM; LOD scores ranging between 0.90 and 2.41), and on chromosome 14p (peak LOD 23 cM; LOD scores ranging between 1.43 and 2.31) </plain></SENT>
<SENT sid="7" pm="."><plain>Ordered subset analysis (OSA) suggests that the linked chromosome 3 region consists of at least two separate loci on 3p and 3q </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, OSA based on <z:chebi fb="23" ids="18059">lipid</z:chebi> measures and other traits identify family subsets with significantly stronger evidence of linkage (e.g., CVD2 on chromosome 3 at 87 cM subsetting on low <z:chebi fb="17" ids="39025">HDL</z:chebi> with an initial LOD of 2.19 is maximized to an LOD of 7.04 in a subset of 25% of the families and CVD2 on chromosome 14 at 22 cM subsetting on high <z:chebi fb="4" ids="17855">triglycerides</z:chebi> with an initial LOD of 1.99 maximized to an LOD of 4.90 in 44% of the families) </plain></SENT>
<SENT sid="9" pm="."><plain>When subjects are defined as affected by the presence of each trait (type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, CVD1, and <z:chebi fb="97" ids="35889">CCP</z:chebi>), significant evidence for linkage to the 3p locus is observed with a peak LOD of 4.13 at 87 cM </plain></SENT>
<SENT sid="10" pm="."><plain>While the correlated nature of the traits makes it unclear whether these loci represent distinct type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> loci or single loci with pleiotropic effects, the coincident linkage suggests that identification of the underlying genes may help clarify the relationship of <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
</text></document>